ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
ed in different studies classified as: duodenal carcinoid; duodenal gastroenteropancreatic (GEP) tumor; duodenal pancreatic neuroendocrine tumor (p-NET); duodenal gastrinoma; duodenal somatostatinoma; gangliocytic paraganglioma; ampullary carcinoid or somatostatinoma; argentaffin carcinoid-producing serotonin of the duodenum; psammomatous somatostatinoma; duodenal NE carcinoma, poorly differentiated and small-cell NE carcinoma of the duodenum [6] . The clinical and management aspect of duodenal gastrinomas are included in the ‘Endocrine Tumors of the Pancreas – Gastrinoma’ section and duodenal gastrinomas will only be considered in this section in comparison with the other d-NENs. Introduction Gastric neuroendocrine neoplasms (g-NENs) [1] are increasingly recognized due to expanding indications of upper gastrointestinal (UGI) endoscopy. Often silent and benign, g-NENs may, however, be aggressive when sporadic and may sometimes mimic the course of gastric adenocarcinoma. Duodenal neuroendocrine tumors (d-NENs) [2] may or may not be associated with a functional clinical syndrome. The term d-NEN includes all duodenal tumors with neuroendocrine (NE) features as determined by histological/immunohistochemical methods including positivity for NE cytosolic markers (neuron-specific enolase (NSE), PGP 9.5) or secretory vesicle proteins (chromogranin A (CgA), synaptophysin) and also frequently the presence of specific gastrointestinal (GI) hormones [3–8] . The term d-NEN in this paper refers to tumors includ- Published online: February 15, 2012 Gianfranco Delle Fave Digestive and Liver Disease Unit ‘Sapienza’ University of Rome, Sant’Andrea Hospital Via Di Grottarossa 1035–1039, IT–00189 Rome (Italy) Tel. +39 06 3377 5691, E-Mail gianfranco.dellefave @ uniroma1.it © 2012 S. Karger AG, Basel 0028–3835/12/0952–0074$38.00/0 Accessible online at: www.karger.com/nen 1
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These tumors develop as a consequence of the parietal cell loss, which leads to reduced gastric acid secretion and downstream persistent hypergastrinemia, enterochromaffin-like cell (ECL) hyperplasia, and, in a small percentage, ECL dysplasia and gastric NETs.27”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [27]
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Apoptosis. Its significance in cancer and cancer Therapy
Kerr, J. F. R., Winterford, C. M., & HARMON, B. V. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2157::aid-cncr2820730821>3.0.co;2-1 · Cited by 2,135
(2011) · Hepatogastroenterology · doi:10.5754/hge11589 · Cited by 1,756
Paraganglioma of the filum terminale internum
Kamalian, N., Abbassioun, K., Amirjamshidi, A., & Shams-Shahrabadi, M. (1987) · Journal of Neurology · doi:10.1007/bf00314201 · Cited by 1,594
Report of a case and review of the literature
Kamalian, N., Abbassioun, K., Amirjamshidi, A., et al. (1987) · Cited by 1,576
THE CLASSIFICATION OF CARCINOID TUMOURS
WILLIAMS, E. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Self-citationThe Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Self-citation
Research works printed but not linked: 30
- Attanoos R, 1991, Semin Diagn Pathol, 8, 149
- Soga J, 1996, J Exp Clin Cancer Res, 15, 3
- Bordi C, 1999, Ital J Gastroenterol Hepatol, 31, S94
- Thomas RM, 1994, Cancer, 73, 2053, 10.1002/1097-0142(19940415)73:8<2053::aid-cncr2820730807>3.0.co;2-0 · DOI · Paper page
- Cattan D, 1991, Gastroenterol Clin Biol, 15, 30C
- Marignani M, 1999, Am J Gastroenterol, 94, 766
- Spinazzola AJ, 1963, Am Surg, 29, 405
- Walton GF, 1997, Am Surg, 63, 302
- Soga J, 1999, J Exp Clin Cancer Res, 18, 13
- Taccagni GL, 1986, Am J Gastroenterol, 81, 33
- Burke AP, 1990, Arch Pathol Lab Med, 114, 700
- Capella C, 1990, Hepatogastroenterology, 37, 247
- Heymann MF, 2004, Hepatogastroenterology, 51, 1367
- Soga J, 2003, J Exp Clin Cancer Res, 22, 349
- Thom AK, 1991, Surgery, 110, 1086
- Zogakis TG, 2003, Ann Surg, 238, 42
- Gibril F, 2004, Medicine, 83, 43, 10.1097/01.md.0000112297.72510.32 · DOI · Paper page
- Cohen T, 1981, Am J Gastroenterol, 75, 197
- Amano S, 1978, Acta Pathol Jpn, 28, 721
- Orbuch M, 1995, Karger, 23, 268
- Yoshikane H, 1995, Am J Gastroenterol, 90, 642
- Meijer WG, 2003, J Nucl Med, 44, 184
- Lebtahi R, 1999, J Nucl Med, 40, 1602
- Hubalewska-Dydejczyk A, 2005, Nucl Med Rev Cent East Eur, 8, 155
- Taal BG, 2005, Minerva Gastroenterol Dietol, 51, 335
- Sato T, 2005, Hepatogastroenterology, 52, 678
- Horsley GW, 1957, Surg Gynecol Obstet, 105, 417
- Thompson GB, 1985, Surgery, 98, 1054
- Yoshikane H, 1993, Gastrointest Endosc, 39, 375, 10.1016/s0016-5107(93)70109-1 · DOI
- Kwekkeboom DJ, 2005, J Nucl Med, 46, 62S
Cited by
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
“These tumors develop as a consequence of the parietal cell loss, which leads to reduced gastric acid secretion and downstream persistent hypergastrinemia, enterochromaffin-like cell (ECL) hyperplasia, and, in a small percentage, ECL dysplasia and gastric NETs.(27) Based on longitudinal cohort studies, the incidence ra…”
BackgroundInfluentialFalconi, M., Bartsch, D. K., Eriksson, B., Klöppel, G., Lopes, J. M., O'Connor, J. M., Salazar, R., Taal, B. G., Vullierme, M. P., & O'Toole, D. (2012) · Neuroendocrinology · doi:10.1159/000335587 · Cited by 526
Self-citationENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Delle Fave, G., O''Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443168 · Cited by 495
Self-citationDeprez, P. H., Moons, L. M. G., OʼToole, D., Gincul, R., Seicean, A., Pimentel-Nunes, P., Fernández-Esparrach, G., Polkowski, M., Vieth, M., Borbath, I., et al. (2022) · Endoscopy · doi:10.1055/a-1751-5742 · Cited by 384
“In these cases, most guidelines recommend surveillance with repeat endoscopy every 1 – 2 years [72,75], and also for adenocarcinoma screening in the atrophic mucosa.”
BackgroundPanzuto, F., Ramage, J., Pritchard, D. M., van Velthuysen, M. F., Schrader, J., Begum, N., Sundin, A., Falconi, M., & O'Toole, D. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13306 · Cited by 180
Metadata
- Authors
- Delle Fave, G., Kwekkeboom, D. J., Van Cutsem, E., Rindi, G., Kos-Kudla, B., Knigge, U., Sasano, H., Tomassetti, P., Salazar, R., & Ruszniewski, P.
- Affiliations
- Hôpital Louis-Mourier (FR)
- Agostino Gemelli University Polyclinic (IT)
- Copenhagen University Hospital (DK)
- Tohoku University (JP)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Hôpital Beaujon (FR)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 95
- Issue
- 2
- Pages
- 74-87
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2158048233
- Cited by
- 327
- References
- 138
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 14 · 2023: 27 · 2022: 25 · 2021: 22 · 2020: 22 · 2019: 17 · 2018: 18 · 2017: 22 · 2016: 36 · 2015: 45 · 2014: 27 · 2013: 19 · 2012: 9
- FWCI
- 23.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- neuroendocrine tumors, consensus recommendations, clinical management, gastrinoma, pancreatic neuroendocrine tumors
- MeSH terms
- Duodenal Neoplasms, Humans, Stomach Neoplasms, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. https://app.cochat.ai/papers/10.1159/000335595
- The paper
- Delle Fave, G., Kwekkeboom, D. J., Van Cutsem, E., Rindi, G., Kos-Kudla, B., Knigge, U., Sasano, H., Tomassetti, P., Salazar, R., & Ruszniewski, P. (2012). ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. Neuroendocrinology. https://doi.org/10.1159/000335595
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.